This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Review
Pharmacodynamic optimization of β-lactams in the patient care setting
-
Correspondence: David P Nicolau dnicola@harthosp.org
Critical Care 2008, 12(Suppl 4):S2 doi:10.1186/cc6818
No comments have yet been made on this article.